Technical Analysis for AZNCF - Astrazeneca Plc Ord
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
20 DMA Resistance | Bearish | 3.16% | |
MACD Bullish Signal Line Cross | Bullish | 3.16% | |
NR7 | Range Contraction | 3.16% | |
Gapped Down | Weakness | 4.11% | |
Fell Below 20 DMA | Bearish | 4.45% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Rose Above 20 DMA | about 9 hours ago |
Rose Above Upper Bollinger Band | about 9 hours ago |
Rose Above 50 DMA | about 9 hours ago |
Rose Above Previous Day's High | about 9 hours ago |
Up 5% | about 9 hours ago |
Get a Trading Sidekick!
Astrazeneca Plc Ord Description
AstraZeneca PLC discovers, develops, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, gastrointestinal, neuroscience, and infection diseases worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL4, Tenormin5, and Zestril6 for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo4 for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a strategic partnership with Bicycle Therapeutics; and with Biothera Pharmaceuticals, Inc. to evaluate cancer related drugs, as well as has a collaboration agreement with Innate Pharma S.A. for oncology development. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC has clinical collaboration with Immunomedics, Inc. for the development of Imfinzi(R) and sacituzumab govitecan combination therapy, to include second-line metastatic non-small cell lung cancer. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Chemistry Cancer Partnership Organic Compounds Chemical Compounds Small Cell Bicycle Cardiovascular Disease Neuroscience Primary Care Metabolic Diseases Lung Cancer Metabolic Disease Rimi Vascular Diseases Cardiovascular Diseases Nexi Qt Small Cell Lung Cancer Bristol Myers Squibb Chloroarenes Dax Byd Respiratory Diseases Astrazeneca Respiratory Disease Xr Idex Zest Combination Therapy Gastrointestinal Diseases Seroquel Xr Tecan
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 143.9 |
52 Week Low | 105.26 |
Average Volume | 2,456 |
200-Day Moving Average | 120.6336 |
50-Day Moving Average | 130.4368 |
20-Day Moving Average | 127.1655 |
10-Day Moving Average | 125.8320 |
Average True Range | 4.6217 |
RSI | 54.75 |
ADX | 9.05 |
+DI | 32.2332 |
-DI | 24.5472 |
Chandelier Exit (Long, 3 ATRs) | 121.3649 |
Chandelier Exit (Short, 3 ATRs) | 133.8651 |
Upper Bollinger Bands | 133.4635 |
Lower Bollinger Band | 120.8675 |
Percent B (%b) | 0.81 |
BandWidth | 9.9052 |
MACD Line | -0.9454 |
MACD Signal Line | -1.4087 |
MACD Histogram | 0.4633 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 135.2650 | ||||
Resistance 3 (R3) | 135.7300 | 134.8000 | 134.5675 | ||
Resistance 2 (R2) | 134.8000 | 133.7342 | 134.5675 | 134.3348 | |
Resistance 1 (R1) | 132.9400 | 133.0758 | 132.4750 | 132.4750 | 134.1024 |
Pivot Point | 132.0100 | 132.0100 | 131.7775 | 131.7775 | 132.0100 |
Support 1 (S1) | 130.1500 | 130.9442 | 129.6850 | 129.6850 | 128.0576 |
Support 2 (S2) | 129.2200 | 130.2858 | 128.9875 | 127.8252 | |
Support 3 (S3) | 127.3600 | 129.2200 | 127.5925 | ||
Support 4 (S4) | 126.8950 |